Complete androgen insensitivity syndrome: Diagnosis and management

Expert Review of Endocrinology and Metabolism

Volumn 4, Issue 6, 2009, Pages 565-573

  Cheikhelard, Alaa ^a   Thibaud, Elisabeth ^a   Morel, Yves ^b   Jaubert, Francis ^a,c   Lortat Jacob, Stephen ^a   Polak, Michel ^a,c   Nihoul Fekete, Claire ^a,c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Androgen receptor; Disorder of sexual development; Ethics; Genotype; Gonadectomy; Testis; Vagina

Indexed keywords

ANDROGEN RECEPTOR; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; FOLLITROPIN; GESTAGEN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; TESTOSTERONE;

ANDROGEN INSENSITIVITY SYNDROME; DIAGNOSTIC ACCURACY; ESTROGEN BLOOD LEVEL; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GONADAL DISEASE; GONADECTOMY; GONADOBLASTOMA; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; INCIDENCE; INGUINAL HERNIA; KARYOTYPE; KARYOTYPE 46,XY; LOW DRUG DOSE; OSTEOPENIA; OSTEOPOROSIS; PARTIAL ANDROGEN INSENSITIVITY SYNDROME; PATHOPHYSIOLOGY; PHENOTYPE; PRENATAL DIAGNOSIS; PRIMARY AMENORRHEA; PRIORITY JOURNAL; PROSTATE DISEASE; PSYCHOLOGICAL ASPECT; PUBERTY; REVIEW; ROUND LIGAMENT OF UTERUS; SEMINOMA; SERTOLI CELL; SEXUAL FUNCTION; TESTOSTERONE BLOOD LEVEL; VIRILIZATION; X CHROMOSOME LINKED DISORDER;

EID: 70449853860     PISSN: 17446651     EISSN: None     Source Type: Journal    
DOI: 10.1586/eem.09.31     Document Type: Review

References (68)

1. Morris JM. The syndrome of testicular feminization in male pseudohermaphrodites. Am. J. Obstet. Gynecol. 65, 1192-1211 (1953).
2. Ahmed SF, Cheng A, Dovey L et al. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J. Clin. Endocrinol. Metab. 85(2), 658-665 (2000). (Pubitemid 32273650)
3. Wisniewski AB, Migeon CJ, Meyer-Bahlburg HF et al. Complete androgen insensitivity syndrome: long-term medical, surgical, and psychosexual outcome. J. Clin. Endocrinol. Metab. 85(8), 2664-2669 (2000).
4. Boehmer AL, Brinkmann O, Brüggenwirth H et al. Genotype versus phenotype in families with androgen insensitivity syndrome. J. Clin. Endocrinol. Metab. 86(9), 4151-4160 (2001).
5. Melo KF, Mendonca BB, Billerbeck AE et al. Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. J. Clin. Endocrinol. Metab. 88(7), 3241-3250 (2003).
6. Cheikhelard A, Morel Y, Thibaud E et al. Long-term follow-up and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome. J. Urol. 180(4), 496-501 (2008).
7. Purves JT, Miles-Thomas J, Migeon C, Gearhart JP. Complete androgen insensitivity: the role of the surgeon. J. Urol. 180(4 Suppl.), 1716-1719 (2008).
8. Minto CL, Liao KL, Conway GS et al. Sexual function in women with complete androgen insensitivity syndrome. Fertil. Steril. 80(1), 157-164 (2003).
9. Hines M, Ahmed SF, Hughes IA. Psychological outcomes and genderrelated development in complete androgen insensitivity syndrome. Arch. Sex. Behav. 32(2), 93-101 (2003). (Pubitemid 38101828)
10. Deeb A, Hughes IA. Inguinal hernia in female infants: a cue to check the sex chromosomes? BJU Int. 96(3), 401-403 (2005). (Pubitemid 41097690)
11. Gottlieb B, Beitel LK, Wu JH, Trifiro M. The androgen receptor gene mutations database (ARDB): 2004 update. Hum. Mutat. 23(6), 527-533 (2004). (Pubitemid 38720602)
12. Sobel V, Schwartz B, Zhu YS et al. Bone mineral density in the complete androgen insensitivity and 5α-reductase-2 deficiency syndromes. J. Clin. Endocrinol. Metab. 91(8), 3017-3023 (2006). (Pubitemid 44271750)
13. Conn J, Gillam L, Conway GS. Revealing the diagnosis of androgen insensitivity syndrome in adulthood. BMJ 331(7517), 628-630 (2005).
14. Lee PA, Houk CP, Ahmed SF et al. International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Pediatrics 118(2), e488-e500 (2006).
15. Baksu A, Kabukcuoglu F, Baksu B et al. Bilateral sertoli cell adenoma and serous cyst in a patient with androgen insensitivity syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 114(1), 104-107 (2004).
16. Hughes IA, Deeb A. Androgen resistance. Best. Pract. Res. Clin. Endocrinol. Metab. 20(4), 577-598 (2006).
17. Galani A, Kitsiou-Tzeli S, Sofokleous C et al. Androgen insensitivity syndrome: clinical features and molecular defects. Hormones (Athens) 7(3), 217-229 (2008).
18. Hannema SE, Scott IS, Rajpert-De Meyts E et al., Testicular development in the complete androgen insensitivity syndrome. J. Pathol. 208(4), 518-527 (2006). (Pubitemid 43329338)
19. Sarpel U, Palmer SK, Dolgin SE. The incidence of complete androgen insensitivity in girls with inguinal hernias and assessment of screening by vaginal length measurement. J. Pediatr. Surg. 40(1), 133-136, discussion 136-137 (2005).
20. Hurme T, Lahdes-Vasama T, Makela E et al. Clinical findings in prepubertal girls with inguinal hernia with special reference to the diagnosis of androgen insensitivity syndrome. Scand. J. Urol. Nephrol. 43(1), 42-46 (2009).
21. Bouvattier C, Carel JC, Lecointre C et al. Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J. Clin. Endocrinol. Metab. 87(1), 29-32 (2002).
22. Papadimitriou DT, Linglart A, Morel Y et al. Puberty in subjects with complete androgen insensitivity syndrome. Horm. Res. 65(3), 126-131 (2006).
23. Jorgensen PB, Kjartansdóttir KR, Fedder J. Care of women with XY karyotype: a clinical practice guideline. Fertil. Steril. (2009) (Epub ahead of print).
24. Boukari K, Meduri G, Brailly-Tabard S et al. Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development. J. Clin. Endocrinol. Metab. 94(5), 1818-1825 (2009).
25. Hannema SE, Scott IS, Hodapp J et al. Residual activity of mutant androgen receptors explains Wolffian duct development in the complete androgen insensitivity syndrome. J. Clin. Endocrinol. Metab. 89(11), 5815-5822 (2004). (Pubitemid 39518476)
26. Barbaro M, Oscarson M, Almskog I et al. Complete androgen insensitivity without Wolffian duct development: the AR-A form of the androgen receptor is not sufficient for male genital development. Clin. Endocrinol. (Oxf.) 66(6), 822-826 (2007).
27. Cools M, van Aerde K, Kersemaekers AM et al. Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes. J. Clin. Endocrinol. Metab. 90(9), 5295-5303 (2005). (Pubitemid 41262289)
28. Cheng L, Sung MT, Cossu-Rocca P et al. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J. Pathol. 211(1), 1-9 (2007). (Pubitemid 46092024)
29. Looijenga LH, Hersmus R, Oosterhuis JW et al. Tumor risk in disorders of sex development (DSD). Best Pract. Res. Clin. Endocrinol. Metab. 21(3), 480-495 (2007). (Pubitemid 47393445)
30. Köhler B, Lumbroso S, Leger J et al. Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling. J. Clin. Endocrinol. Metab. 90(1), 106-111 (2005). (Pubitemid 40116641)
31. Nichols JL, Bieber EJ, Gell JS. Case of sisters with complete androgen insensitivity syndrome and discordant Müllerian remnants. Fertil. Steril. 91(3), 932.e.15-932.e.18 (2009).
32. Quigley CA, Friedman KJ, Johnson A. Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J. Clin. Endocrinol. Metab. 74(4), 927-933 (1992).
33. Han TS, Goswami D, Trikudanathan S et al. Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. Eur. J. Endocrinol. 159(2), 179-185 (2008).
34. Frank GR. Role of estrogen and androgen in pubertal skeletal physiology. Med. Pediatr. Oncol. 41(3), 217-221 (2003).
35. Taes Y, Lapauw B, Vandewalle S et al. Estrogen-specific action on bone geometry and volumetric bone density: longitudinal observations in an adult with complete androgen insensitivity. Bone 45(2), 392-397 (2009).
36. Hindmarsh PC. How do you initiate oestrogen therapy in a girl that has not undergone puberty? Clin. Endocrinol. (Oxf.) 71(1), 7-10 (2009).
37. Bertelloni S, Dati E, Baroncelli GI. Disorders of sex development: hormonal management in adolescence. Gynecol. Endocrinol. 24(6), 339-346 (2008). (Pubitemid 351918006)
38. DiVasta AD, Gordon CM. Hormone replacement therapy for the adolescent patient. Ann. NY Acad. Sci. 1135, 204-211(2008).
39. Cools M, Drop SL, Wolffenbuttel KP et al. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr. Rev. 27(5), 468-484 (2006). (Pubitemid 44213228)
40. Iwamoto I, Yanazume S, Fujino T et al. Leydig cell tumor in an elderly patient with complete androgen insensitivity syndrome. Gynecol. Oncol. 96(3), 870-872 (2005). (Pubitemid 40255517)
41. Talerman A, Roth LM. Recent advances in the pathology and classification of gonadal neoplasms composed of germ cells and sex cord derivatives. Int. J. Gynecol. Pathol. 26(3), 313-321 (2007). (Pubitemid 46986069)
42. Horcher E, Grünberger W, Parschalk O. Classical seminoma in a case of testicular feminization syndrome. Prog. Pediatr. Surg. 16, 139-141 (1983).
43. Hurt WG, Bodurtha JN, McCall JB et al. Seminoma in pubertal patient with androgen insensitivity syndrome. Am. J. Obstet. Gynecol. 161(3), 530-531 (1989).
44. Rutgers JL, Scully RE. The androgen insensitivity syndrome (testicular feminization): a clinicopathologic study of 43 cases. Int. J. Gynecol. Pathol. 10(2), 126-144 (1991).
45. Lloyd J, Crouch NS, Minto CL et al. Female genital appearance: 'normality' unfolds. BJOG 112(5), 643-646 (2005).
46. Ismail-Pratt IS, Bikoo M, Liao LM et al. Normalization of the vagina by dilator treatment alone in complete androgen insensitivity syndrome and Mayer- Rokitansky-Kuster-Hauser syndrome. Hum. Reprod. 22(7), 2020-2024 (2007). (Pubitemid 47062773)
47. Mazur T. Gender dysphoria and gender change in androgen insensitivity or micropenis. Arch. Sex. Behav. 34(4), 411-421 (2005). (Pubitemid 40980274)
48. Reiner WG. Gender identity and sex-ofrearing in children with disorders of sexual differentiation. J. Pediatr. Endocrinol. Metab. 18(6), 549-553 (2005).
49. Danilovic DL, Correa PH, Costa EM et al. Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene. Osteoporos. Int. 18(3), 369-374 (2007).
50. Vanderschueren D, Vandenput L, Boonen S et al. Androgens and bone. Endocr. Rev. 25(3), 389-425 (2004).
51. Salmasi AH, Wisniewski AB, Novak TE et al. Prostate screening in patients with 46,XY disorders of sex development - is it necessary? J. Urol. 180(4), 1422-1425 (2008).
52. Robboy SJ, Jaubert F. Neoplasms and pathology of sexual developmental disorders (intersex). Pathology 39(1), 147-163 (2007). (Pubitemid 46310780)
53. Kerkhofs S, Denayer S, Haelens A et al. Androgen receptor knockout and knock-in mouse models. J. Mol. Endocrinol. 42(1), 11-17 (2009).
54. Berg JS, French SL, McCullough LB et al. Ethical and legal implications of genetic testing in androgen insensitivity syndrome. J. Pediatr. 150(4), 434-438 (2007).
55. Quigley CA, De Bellis A, Marschke KB et al. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr. Rev. 16(3), 271-321 (1995).
56. Werner R, Zhan J, Gesing J et al. In-vitro characterization of androgen receptor mutations associated with complete androgen insensitivity syndrome reveals distinct functional deficits. Sex. Dev. 2(2), 73-83 (2008). (Pubitemid 351896583)
57. Davies MC, Creighton SM, Woodhouse CR. The pitfalls of vaginal construction. BJU Int. 95(9), 1293-1298 (2005).
58. Burgu B, Duffy PG, Cuckow P et al. Long-term outcome of vaginal reconstruction: comparing techniques and timing. J. Pediatr. Urol. 3(4), 316-320 (2007). (Pubitemid 46959174)
59. Johannsen TH, Ripa CP, Mortensen EL et al. Quality of life in 70 women with disorders of sex development. Eur. J. Endocrinol. 155(6), 877-885 (2006).
60. Oakes MB, Eyvazzadeh AD, Quint E et al. Complete androgen insensitivity syndrome - a review. J. Pediatr. Adolesc. Gynecol. 21(6), 305-310 (2008).
61. Heller-Boersma JG, Schmidt UH, Edmonds DK. A randomized controlled trial of a cognitive-behavioural group intervention versus waiting-list control for women with uterovaginal agenesis (Mayer-Rokitansky-Küster-Hauser syndrome: MRKH). Hum. Reprod. 22(8), 2296-2301(2007).
62. Heller-Boersma JG, Edmonds DK, Schmidt UH. A cognitive behavioural model and therapy for utero-vaginal agenesis (Mayer-Rokitansky-Küster-Hauser syndrome: MRKH). Behav. Cogn. Psychother. 37(4), 449-467 (2009).
63. Bilezikian JP. Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis. Am. J. Med. 122(2 Suppl.), S14-S21 (2009).
64. Dennis C. Brain development: the most important sexual organ. Nature 427(6973), 390-392 (2004).
65. Arnold AP, Xu J, Grisham W et al. Minireview: Sex chromosomes and brain sexual differentiation. Endocrinology 145(3), 1057-1062 (2004). (Pubitemid 38280982)
66. The Androgen Receptor Gene Mutations Database World Wide Web Serve www.mcgill.ca/androgendb/
67. Androgen Insensitivity Syndrome Support Group www.aissg.org
68. The portal for rare diseases and orphan drugs www.orpha.net